Home
OrbiMed Capital GP VI, Director: Edgewise Therapeutics EWTX Buy · Filed 24/01/25
Trade details
- Type
- Insider buy
- Amount
- $4,999,995
- Shares · price
- 454,545 sh · $11.00 a share
- Held after
- 14,436,497 sh
- Trade date
- 24/01/23
- Filed
- 24/01/25
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 4 insiders
- Holding change
- +3.3%
Edgewise Therapeutics trades, last 26 weeks
What else happened in Edgewise Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/24~24/02/22OrbiMed Capital GP VI's recent trades
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07
